feed,title,long_url,short_url
SeekingAlpha,Relief says Nexodyn's trial for rare skin disorder gets IRB approval,https://seekingalpha.com/news/3885165,
SeekingAlpha,"Accenture GAAP EPS of $2.60 beats by $0.03, revenue of $15.42B in-line",https://seekingalpha.com/news/3885166,
